Related Experiment Videos
[Postprandial hyperglycemia. II. Pharmacological approaches]
A J Scheen1, M R Letiexhe, I Geronooz
1Service de Diabétologie, Nutrition et Maladies métaboliques, Département de Médecine, CHU Sart Tilman.
Revue Medicale De Liege
|June 21, 2002
Summary
New medications help control high blood sugar after meals by slowing carbohydrate absorption, improving insulin response, or reducing glucagon secretion. These pharmacological approaches offer better postprandial hyperglycemia management.
Area of Science:
- Endocrinology
- Pharmacology
- Metabolic Diseases
Background:
- Postprandial hyperglycemia is a key factor in diabetes management.
- Dietary interventions alone are often insufficient for optimal glycemic control.
Purpose of the Study:
- To review pharmacological strategies for controlling postprandial hyperglycemia.
- To discuss mechanisms including slowed carbohydrate absorption, enhanced insulin secretion, and inhibited glucagon action.
Main Methods:
- Review of hormonal agents (amylin, glucagon-like peptide-1) affecting gastric emptying.
- Analysis of alpha-glucosidase inhibitors (acarbose, miglitol) for carbohydrate digestion.
- Evaluation of insulin secretagogues (glinides) and rapid-acting insulin analogs for mealtime insulin profiles.
Main Results:
- Hormones like amylin and GLP-1 slow gastric emptying.
- Alpha-glucosidase inhibitors delay carbohydrate absorption.
- Glinides and fast-acting insulin analogs improve post-meal insulin profiles.
Conclusions:
- Pharmacological interventions offer multiple pathways to manage postprandial hyperglycemia.
- These agents target carbohydrate absorption, insulin release, and glucagon activity for improved glycemic control.